Altimmune, Inc. (ALT) Tops Q2 EPS by 4c

Altimmune, Inc. (NASDAQ: ALT) reported Q2 EPS of ($0.27), $0.04 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Active options: NVDA TSLA SPCX AAPL AMZN MU INTC NFLX MSFT PLTR